Sight Sciences Inc SGHT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $5.34
- Day Range
- $5.00–5.40
- 52-Week Range
- $3.11–9.24
- Bid/Ask
- $2.04 / $5.33
- Shares Outstanding
- 54.41M
- Market Cap
- $274.77M
- Volume/Avg
- 107,207 / 238,698
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.35
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 186
- Website
- https://www.sightsciences.com
Valuation
|
Metric
|
SGHT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 5.06 |
Price/Sales | 3.35 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
SGHT
|
|---|---|
Quick Ratio | 5.26 |
Current Ratio | 5.86 |
Interest Coverage | −6.24 |
Quick Ratio
SGHT
Profitability
|
Metric
|
SGHT
|
|---|---|
Return on Assets (Normalized) | −21.58% |
Return on Equity (Normalized) | −38.81% |
Return on Invested Capital (Normalized) | −19.15% |
Return on Assets
SGHT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|^l>k>#c | LOCK|pTRz | $155B | |||
| Stryker Corp
SYK
| LOCK|cfl!HR$ | LOCK|t%< | $119B | |||
| Medtronic PLC
MDT
| LOCK|ssJpX$ | LOCK|jTxW% | $102B | |||
| Boston Scientific Corp
BSX
| LOCK|%?mxB$v | LOCK|^nPt@ | $63B | |||
| Edwards Lifesciences Corp
EW
| LOCK|$^?j>M?R | LOCK|r&P@d | $52B | |||
| DexCom Inc
DXCM
| LOCK|!Q#G&$BZ | LOCK|%F<$ | $29B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|$%c^l< | LOCK|zXR | $28B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|m% | LOCK|$^& | $25B | |||
| Steris PLC
STE
| LOCK|?$jz!#@ | LOCK|B<g<l | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|%KSXLg&? | LOCK|FR& | $18B |
United States